Clinical Trials
49 trialsExtracellular RNA Markers of Liver Disease and Cancer
Mayo Clinic
BIOSUNTOX
University Hospital, Rouen
Study of Combined Decompressive Spine Radiosurgery and Pembrolizumab
Wake Forest University Health Sciences
Gemcitabine and Docetaxel With Radiation in Adults With Soft Tissue Sarcoma of the Extremities
Wake Forest University Health Sciences
Glutamine PET Imaging Colorectal Cancer
M.D. Anderson Cancer Center
AMBROBiMM
Assistance Publique - Hôpitaux de Paris
PAIR HPV
Institut Curie
SynBioDiag
University Hospital, Montpellier
The Safety and Feasibility of Costal Bone Marrow Aspiration During Thoracic Surgery
Universitair Ziekenhuis Brussel
Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics
Mayo Clinic
FIT
Western Sydney Local Health District
64Cu-LLP2A for Imaging Multiple Myeloma
Washington University School of Medicine
LUTON
Hospices Civils de Lyon
Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy
Washington University School of Medicine
Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence
Mayo Clinic
Bioenergetic Profiling and Cognition in GBM Patients
Wake Forest University Health Sciences
REVOLUMHOD
Rennes University Hospital
Use Peripheral Blood Proteomics to Predict the Treatment Response and Toxicities in NSCLC Immunotherapy
University of Iowa
Exhaled Breath Analysis to Predict Risk of Symptomatic Pneumonitis
Wake Forest University Health Sciences
FRACTal
Institut Curie
Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies
Masonic Cancer Center, University of Minnesota
ELICIT
Radboud University Medical Center
REPOSIT
Netherlands Working Group on Immunotherapy of Oncology
Sample Collection From Melanoma Patients
M.D. Anderson Cancer Center
MYOCAC
Centre Hospitalier Universitaire de Saint Etienne
Memory Phenotype and PD-1 Inhibition Response in Oral Cancer
Medical University of South Carolina
Explor-AVD
Hopital Foch
Gut Microbiome & Gastrointestinal Toxicities as Determinants of Response to Neoadjuvant Chemo for Advanced Breast Cancer
University of Arkansas
Metabolic and Microbial Profiling of Lung Cancer
Wake Forest University Health Sciences
PALTAN
Washington University School of Medicine
Circulating Tumor Cells in Prostate Cancer Patients
University of Texas Southwestern Medical Center
Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis
Dana-Farber Cancer Institute
DPD côlon
Institut Cancerologie de l'Ouest
BACCHUS
Centre Hospitalier Universitaire de Saint Etienne
Identification of Key Blood Molecular Markers for Immunotherapy
Stanford University
Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery
Vanderbilt-Ingram Cancer Center
Anti-inflammatory Cells in Peritoneal Cavity
University Hospital, Montpellier
CPCT-01
UMC Utrecht
GnRHA Therapy and Ovarian Preservation in Pediatric Cancer Patient
University of Kentucky
Genetic Basis of Hemangiomas
Medical College of Wisconsin
Relation Between Safety Endpoints and Everolimus Trough Blood Level in Advanced Renal Cell Carcinoma
Centre Francois Baclesse
Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer
Hoosier Cancer Research Network
Gliomstudien
Haukeland University Hospital
Metabolism of Lipids in Advanced Cancer
AHS Cancer Control Alberta
CIRCUBRONCH
Central Hospital, Nancy, France
A 12-Gene Blood-Based Signature for Detecting Metastatic Bladder Cancer
Memorial Sloan Kettering Cancer Center
Search a Correlation Between Lp(a) Rate and TFPI Activity in Obese Patients With Chest Pain Like Angina
Centre Hospitalier Universitaire de Saint Etienne
PhII Study STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas Cancer
Vanderbilt-Ingram Cancer Center
Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins